SCHEMBL21276770

SCHEMBL21276770

O=CNc1ccc(C#Cc2ccc(OCCN3CCOCC3)cn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 9/20 0.50
▸ CHRM1 P11229 2/20 0.50
▸ HTR2A P28223 2/20 0.50
▸ CYP2D6 P10635 2/20 0.50
▸ ACACB O00763 1/20 0.48
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ KMT2A Q03164 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ HRH2 P25021 1/20 0.44
▸ HRH1 P35367 1/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21276670 0.96 MCHR1 (0.50) MCHR1CHRM1HTR2ACYP2D6ACACB
SCHEMBL21276824 0.91 HRH3 (0.51) MCHR1CHRM1HTR2ACYP2D6CYP1A2
SCHEMBL21276771 0.88 MCHR1 (0.49) MCHR1CHRM1HTR2ACYP2D6ACACB
SCHEMBL21276708 0.86 HRH3 (0.59) CHRM1HTR2AACACBCYP1A2HRH2
SCHEMBL14368318 0.86 CA12 (0.58) CHRM1HTR2ACYP2D6CA12CA1
SCHEMBL21276827 0.83 MCHR1 (0.45) MCHR1CYP2D6ACACBCA12CA1
SCHEMBL21276690 0.81 PRKAB1 (0.47) ACACB
SCHEMBL21757567 0.80 HRH3 (0.63) CHRM1HTR2ACYP1A2HRH2HRH1
SCHEMBL21276751 0.79 HRH3 (0.54) MCHR1CHRM1HTR2ACYP2D6CYP1A2
SCHEMBL21757596 0.79 TSHR (0.66) CHRM1HTR2ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3169671-B1 1-(5-(TERT.-BUTYL)ISOXAZOL-3-YL)-3-(4-((PHENYL)ETHYNYL)PHENYL)UREA DERIVATIVES AND RELATED COMPOUNDS AS FLT3 INHIBITORS FOR TREATING CANCER SUNSHINE LAKE PHARMA CO LTD (CN) 2019-08-21 — — EP disclosed
Send feedback